EMBL’s European Bioinformatics Institute (EMBL-EBI) and Google DeepMind today announced the renewal of their collaboration on the AlphaFold Protein Structure Database (AFDB) – a landmark partnership ...
Generative A.I. can do many things human beings can do. But that misses the point about how A.I. can truly benefit us.
In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug ...
A University of Alberta research team has uncovered a new role for a genetic mutation previously known to be linked to ...
When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer ...
In the hunt for new therapeutics for cancer and infectious diseases, lasso peptides prove to be a catch. Their knot-like ...
AlphaFold 3 (AF3), the latest AI model from Google DeepMind and Isomorphic Labs, can predict the structures and interactions ...
News-Medical.Net on MSN
Researchers design intrinsically disordered proteins with tailored properties
In synthetic and structural biology, advances in artificial intelligence have led to an explosion of designing new proteins with specific functions, from antibodies to blood clotting agents, by using ...
AI and quantum computing will accelerate medical breakthroughs, potentially doubling human lifespan and revolutionizing disease treatment. Alphabet is uniquely positioned to lead in healthspan and ...
However, Kay worried that humans are easily fooled and that AI companies cannot always explain how their models produce the ...
Some researchers think artificial intelligence could produce Nobel-worthy research, but others question whether autonomous AI scientists are possible or even desirable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback